Advertisement

Organisation › Details
BeiGene Switzerland GmbH
![]() |
Start | 2018-10-11 existent |
Group | BeOne Medicines (Group) (formerly BeiGene) | |
![]() |
Industry | pharmaceutical |
![]() |
Region | Basel BS |
Country | Switzerland | |
Street | 27 Aeschengraben 21st Floor | |
City | 4051 Basel | |
Address record changed: 2022-05-17 | ||
Basic data | Employees | D: 101 to 500 (2022-05-17) |
Record changed: 2024-12-29 |
Advertisement

More documents for BeOne Medicines (Group) (formerly BeiGene)
- [1] BeiGene, Ltd.. (12/23/24). "Press Release: BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference". San Mateo, CA....
- [2] BeiGene, Ltd.. (9/19/23). "Press Release: BeiGene Strengthens Global Portfolio and Regains Full Rights from Novartis for Anti-PD-1 Antibody Tevimbra (tislelizumab)". Basel & Beijing & Cambridge, MA....
- [3] BeiGene, Ltd.. (7/13/22). "Press Release: BeiGene Appoints Chan Lee as General Counsel". Cambridge, MA, Basel & Beijing....
- [4] BeiGene, Ltd.. (5/17/22). "Press Release: BeiGene Strengthens European Presence With the Opening of Regional Office in Basel, Switzerland". Cambridge, MA, Basel & Beijing....
- [5] Celeris Therapeutics GmbH. (2/24/22). "Press Release: CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors". Menlo Park, CA....
- [6] Novartis AG. (12/20/21). "Press Release: Novartis Strengthens Immunotherapy Pipeline with Option, Collaboration and License Agreement with BeiGene for TIGIT inhibitor Ociperlimab". Basel....
- [7] BeiGene, Ltd.. (11/23/21). "Press Release: BeiGene Closes on Property for New U.S. Manufacturing and Clinical R&D Center". Hopewell, NJ, Cambridge, MA & Beijing....
- [8] BeiGene, Ltd.. (11/23/21). "Press Release: BeiGene Launches Proposed Initial Public Offering on the STAR Market in China". Cambridge, MA & Beijing....
- [9] BeiGene, Ltd.. (11/23/21). "Press Release: BeiGene Announces Approval of Brukinsa (zanubrutinib) in the European Union for Treatment of Adults with Waldenström’s Macroglobulinemia". Basel, Cambridge, MA & Beijing....
- [10] Novartis AG. (1/11/21). "Press Release: Novartis Expands Oncology Pipeline with In-licensing of Tislelizumab from BeiGene". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top